Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity...
31 insider purchases on record · latest filing 2026-06-17.
Insiders have also filed 64 sale transactions at OCGN.